Insiders Exagen Inc.

Equities

Market Closed - Nasdaq Other stock markets 21:30:01 10/05/2024 BST			5-day change	1st Jan Change
1.57 ^USD	+11.35%		+12.14%	-21.11%

04-26	Exagen Inc. Announces Changes in Board of Directors	CI
03-18	Exagen Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Exagen Inc. Announces Changes in Board of Directors	04-26	CI
Exagen Inc. Appoints Paul Kim as Class II Director	24/07/23	CI
Exagen Inc. Announces Board Changes	23/03/23	CI
Exagen Inc. Announces Board Changes	23/01/23	CI
Insider Buy: Exagen	09/12/22	MT
Exagen Inc. Announces Executive Changes	05/12/22	CI
Exagen Names John Aballi Chief Executive	17/10/22	MT
Exagen Inc. Appoints John Aballi as President	17/10/22	CI
Exagen Inc. Appoints John Aballi as CEO	17/10/22	CI
Exagen Inc. Appoints Andrew L. Concoff as Chief Innovation Officer	04/10/22	CI
Exagen Inc. Announces Board Appointments	16/03/22	CI
Exagen Inc. Appoints Ana Hooker to Board of Directors	30/07/21	CI
Exagen Elects Frank Stokes to Board of Directors	18/06/21	CI
Exagen Inc. Announces Resignation of Chet Burrell from the Board, Effective December 31, 2020	10/11/20	CI
Exagen Inc. Appoints Wendy Johnson as a Class III Director, and to Audit Committee Effective as of October 1, 2020	23/09/20	CI
Exagen Inc. Announces Executive Changes	24/03/20	CI
Exagen Inc. Forms Scientific Advisory Board	10/12/19	CI
Exagen Inc. Announces Resignation of Thierry Dervieux as Chief Scientific Officer, Effective December 9, 2019	22/11/19	CI
Exagen Inc. Expands Board of Directors with Its Appointment of Chet Burrell, Tina Nova and Bruce Robertson	30/07/19	CI
Exagen Inc. Appoints Jeff Elliott as Director	26/03/19	CI

No results for this search